Association of CagA EPIYA-D or EPIYA-C Phosphorylation Sites with Peptic Ulcer and Gastric Cancer Risks: A Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2017 Apr 27

PMID 28445260

Citations 27

Authors

Qiuping Li

Jingwei Liu

Yuehua Gong

Yuan Yuan

Affiliations

Soon will be listed here.

Abstract

Background: Increasingly, studies have focused on the relationship between Helicobacter pylori (H pylori) cytotoxin associated gene A protein (CagA) Glu-Pro-Ile-Tyr-Ala (EPIYA)-D motifs or multiple EPIYA-C phosphorylation sites and peptic ulcer disease (PUD) or gastric cancer (GC) risk. However, the conclusions have been inconsistent. The aim of this meta-analysis was to evaluate whether 1 CagA EPIYA-D motif or multiple EPIYA-C phosphorylation sites were associated with PUD or GC risk.

Materials And Methods: A literature search was performed in PubMed, Web of Science, Wanfang Data, Excerpt Medica Database, and the Chinese National Knowledge Infrastructure database to identify eligible research. We analyzed the odds ratios (OR) and 95% confidence intervals (CI) to assess the strength of association.

Results: Compared with 1 EPIYA-C motif in Asian populations, 1 EPIYA-D site was associated with an increased GC risk (OR=1.91, 95% CI=1.19-3.07, P = .008). However, 1 EPIYA-D motif was not significantly associated with PUD (OR = 0.90, 95% CI = 0.46-1.76, P = .764), gastric ulcer (GU) (OR = 0.85, 95% CI = 0.27-2.63, P = .771), or duodenal ulcer (DU) (OR = 0.89, 95% CI = 0.25-3.16, P = .859) risk. Compared with no more than 1 EPIYA-C motif, multiple motifs were associated with increased PUD (OR = 2.33, 95% CI = 1.29-4.20, P = .005) and DU (OR = 2.32, 95% CI = 1.08-5.00, P = .031) risk in Asia and GC risk in the United States and Europe (OR = 3.28, 95% CI = 2.32-4.64, P < .001). Multiple EPIYA-C sites were not associated with GU risk (OR = 4.54, 95% CI = 0.95-21.83, P = .059). There was no publication bias identified in these comparisons.

Conclusions: In Asia, 1 EPIYA-D motif was significantly associated with increased GC risk. Multiple EPIYA-C motifs were associated with increased PUD and DU risk, particularly in Asia. In the United States and Europe, multiple EPIYA-C motifs were associated with increased GC risk. Therefore, detection of polymorphic CagA EPIYA motifs may improve clinical prediction of disease risk.

Citing Articles

Helicobacter pylori Infection in Colombia: Phylogeny, Resistome, and Virulome.

Munoz A, Stepanian J, Solano-Gutierrez J, Vale F, Trespalacios-Rangel A APMIS. 2025; 133(2):e70003.

PMID: 39930978 PMC: 11811748. DOI: 10.1111/apm.70003.

Helicobacter pylori and gastric cancer: mechanisms and new perspectives.

Duan Y, Xu Y, Dou Y, Xu D J Hematol Oncol. 2025; 18(1):10.

PMID: 39849657 PMC: 11756206. DOI: 10.1186/s13045-024-01654-2.

Amino acid deletions at positions 893 and 894 of cytotoxin-associated gene A protein affect gastric epithelial cell interactions.

Xue Z, Gong Y, He L, Sun L, You Y, Fan D World J Gastroenterol. 2024; 30(41):4449-4460.

PMID: 39534413 PMC: 11551673. DOI: 10.3748/wjg.v30.i41.4449.

Trends in upper gastrointestinal bleeding management.

Khayyat Y World J Clin Cases. 2024; 12(27):6007-6010.

PMID: 39328864 PMC: 11326108. DOI: 10.12998/wjcc.v12.i27.6007.

Genomic insights into the antimicrobial resistance and virulence of Helicobacter pylori isolates from gastritis patients in Pereira, Colombia.

Alvarez-Aldana A, Ikhimiukor O, Guaca-Gonzalez Y, Montoya-Giraldo M, Souza S, Buiatte A BMC Genomics. 2024; 25(1):843.

PMID: 39251950 PMC: 11382513. DOI: 10.1186/s12864-024-10749-6.

References

Hatakeyama M . Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA. Keio J Med. 2003; 51 Suppl 2:26-32. DOI: 10.2302/kjm.51.supplement2_26. View

Mohamed R, Hanafiah A, Rose I, Manaf M, Abdullah S, Sagap I . Helicobacter pylori cagA gene variants in Malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis. 2009; 28(7):865-9. PMC: 2693772. DOI: 10.1007/s10096-009-0712-x. View

Peek Jr R, Blaser M . Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002; 2(1):28-37. DOI: 10.1038/nrc703. View

Salih B, Bolek B, Arikan S . DNA sequence analysis of cagA 3' motifs of Helicobacter pylori strains from patients with peptic ulcer diseases. J Med Microbiol. 2009; 59(Pt 2):144-148. DOI: 10.1099/jmm.0.014894-0. View

Chen C, Wang F, Wan H, Jin X, Wei J, Wang Z . Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center. J Dig Dis. 2013; 14(7):358-65. DOI: 10.1111/1751-2980.12056. View

Basso D, Zambon C, Letley D, Stranges A, Marchet A, Rhead J . Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 2008; 135(1):91-9. DOI: 10.1053/j.gastro.2008.03.041. View

Schneider N, Krishna U, Romero-Gallo J, Israel D, Piazuelo M, Camargo M . Role of Helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential. J Infect Dis. 2009; 199(8):1218-21. PMC: 2828761. DOI: 10.1086/597416. View

Murata-Kamiya N . Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect. 2011; 13(10):799-807. DOI: 10.1016/j.micinf.2011.03.011. View

El-Omar E, Carrington M, Chow W, McColl K, Bream J, Young H . Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000; 404(6776):398-402. DOI: 10.1038/35006081. View

10.

Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H . Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe. 2009; 5(1):23-34. DOI: 10.1016/j.chom.2008.11.010. View

11.

Backert S, Tegtmeyer N, Selbach M . The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter. 2010; 15(3):163-76. DOI: 10.1111/j.1523-5378.2010.00759.x. View

12.

Argent R, Zhang Y, Atherton J . Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J Clin Microbiol. 2005; 43(2):791-5. PMC: 548073. DOI: 10.1128/JCM.43.2.791-795.2005. View

13.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

14.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

15.

Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T . Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002; 99(22):14428-33. PMC: 137900. DOI: 10.1073/pnas.222375399. View

16.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

17.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

18.

Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M . Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002; 123(6):1962-71. DOI: 10.1053/gast.2002.37044. View

19.

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

20.

Vianna J, Ramis I, Bartolomeu Halicki P, Gastal O, Silva R, Junior J . Detection of Helicobacter pylori CagA EPIYA in gastric biopsy specimens and its relation to gastric diseases. Diagn Microbiol Infect Dis. 2015; 83(2):89-92. DOI: 10.1016/j.diagmicrobio.2015.05.017. View